7 articles
The post analyses significant patent and design updates for January 2022, focusing on India’s WTO patent waiver request and RGNIIPM’s training initiative. It also highlights major international patent…
This post analyses World IP Day amid the COVID-19 pandemic, questioning whether intellectual property systems have supported or hindered access to vital medicines. It highlights the limited measures…
The Patents Amendment Rules 2020 have come into effect in India, bringing notable changes to patent filing and reporting requirements. This bulletin covers updates on patent disputes, TRIPS…
If you have any questions, or need any clarifications, please feel free to write to contact@bananaip.com Disclaimer: Kindly note that the news bulletin has been put together from…
India urges TRIPs flexibility at the WTO to aid access to COVID-19 medicines. CNIPA announces its first COVID-19 vaccine patent application, and key global patent office initiatives are…
This post examines India's transition to a TRIPS-compliant patent regime, focusing on Exclusive Marketing Rights and the Mailbox Provision. It outlines legislative changes that facilitated the shift from…
India has protested the European Union's recent trademark reforms, highlighting concerns over potential seizures of legal pharmaceutical shipments in transit. The issue has been raised at the WTO,…